Form 8-K - Current report:
SEC Accession No. 0001213900-25-052718
Filing Date
2025-06-09
Accepted
2025-06-09 17:29:24
Documents
16
Period of Report
2025-06-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0245189-8k_citius.htm   iXBRL 8-K 28900
2 CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF CITIUS PHARMACEUTIC ea024518901ex3-1_citius.htm EX-3.1 2930
6 GRAPHIC ex3-1_001.jpg GRAPHIC 965517
7 GRAPHIC ex3-1_002.jpg GRAPHIC 714048
8 GRAPHIC ex3-1_003.jpg GRAPHIC 530870
  Complete submission text file 0001213900-25-052718.txt   3244728

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ctxr-20250609.xsd EX-101.SCH 3026
4 XBRL LABEL FILE ctxr-20250609_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE ctxr-20250609_pre.xml EX-101.PRE 22366
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0245189-8k_citius_htm.xml XML 3794
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 251035182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)